Vaccines for HIV Prevention: Research
- International AIDS Vaccine Research Database of AIDS Vaccine Candidates in Clinical Trials (Regularly Updated)
From International AIDS Vaccine Initiative
- New HIV Vaccine Candidates Show Promise in Monkeys (January 5, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
 Experimental Vaccine Partially Protects Monkeys From HIV-Like Infection (January 4, 2012)
Study reveals factors associated with prevention, control of HIV infection.
From U.S. National Institute of Allergy and Infectious Diseases
- In Mice, a Step Towards a Vaccine for HIV (December 8, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Scientists Determine How Antibody Recognizes Key Sugars on HIV Surface (November 23, 2011)
NIH-led study advances HIV vaccine research.
From U.S. National Institute of Allergy and Infectious Diseases
- Tennessee: Vanderbilt University Seeks More Men for HIV Vaccine Trial (November 14, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Canada: "Speaking the Dialect" -- Understanding Public Discourse in the Aftermath of an HIV Vaccine Trial Shutdown (November 11, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Health Groups Urge Secretary of U.S. Army to Sustain Funding for Military HIV Research Program (October 14, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Cuts to U.S. Military's HIV Research Program Threaten HIV Vaccine Progress (October 7, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Spanish HIV Vaccine Shows 90 Percent Success in Early Trial (October 5, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Spanish HIV Vaccine Story Gets Lots of Attention -- Here's Why (October 4, 2011)
From Journal Watch
- Small Phase I Trial Shows HIV Vaccine Candidate Is Most Powerful to Date (September 29, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Scientists Find Way to "Disarm" AIDS Virus (September 27, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- HIV Vaccine Research Showing Promise (September 26, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Thailand: AIDS Vaccine Conference Ends With Eye to Future (September 19, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Scientists, Policymakers Meet to Present Recent AIDS Vaccine Developments (September 15, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Is Lack of Communication to Blame for Lackluster HIV Vaccine Participation? (September 8, 2011)
From The Body
- Researchers Discuss Challenges to Developing Broadly Protective HIV Vaccines (September 7, 2011)
New advances provide reason for optimism.
From U.S. National Institute of Allergy and Infectious Diseases
- NIAID Funds New Consortia for AIDS Vaccine Research (August 26, 2011)
Studies will focus on earliest stages of HIV infection.
From U.S. National Institute of Allergy and Infectious Diseases
- Isolation of HIV Antibodies Advances Search for AIDS Vaccine (August 18, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- AIDS Researchers Isolate New Potent and Broadly Effective Antibodies Against HIV (August 17, 2011)
From International AIDS Vaccine Initiative
- U.S. Scientists Expand Scope of HIV Vaccine Study (August 17, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
 NIH-Led Team Maps Route for Eliciting HIV Neutralizing Antibodies (August 11, 2011)
New technique can be used widely to develop vaccines.
From National Institute of Allergy and Infectious Diseases
 HVTN 505 HIV Vaccine Study to Expand Scope (August 4, 2011)
From National Institute of Allergy and Infectious Diseases
- IAVI Report (PDF) (July/August 2011)
From International AIDS Vaccine Initiative
- Georgia: Emory University Receives $26 Million to Study AIDS Vaccine (July 20, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Have Scientists Found HIV's Achilles Heel? (June 21, 2011)
In The Wall Street Journal
- Scientists Apply Math Model to HIV to Discover Targets for Vaccines or Drugs (June 21, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- IAVI Report (PDF) (May/June 2011)
From International AIDS Vaccine Initiative
- Promising New Research on Preventive and Therapeutic HIV Vaccines (May 24, 2011)
From Black AIDS Institute
 What's So Special About Research? Dr. Carl Dieffenbach Answers: A Blog Entry by Candace Y.A. Montague (May 18, 2011)
"Today is National HIV Vaccine Awareness day. It is a day to recognize the thousands of volunteers who have given their time and bodies for research. It is also a day to spotlight how participation in trials is critical in the pursuit of a cure."
From The Body
- University of Maryland Researchers Receive $23.4 Million to Research AIDS Vaccine (May 11, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Antibodies Help Protect Monkeys From HIV-Like Virus, NIH Scientists Show (May 5, 2011)
Finding could aid development of HIV vaccine for humans.
From U.S. National Institute of Allergy and Infectious Diseases
- Adaptive Trial Designs Could Accelerate HIV Vaccine Development (April 20, 2011)
NIH scientists review lessons learned from more than a decade of trials.
From U.S. National Institute of Allergy and Infectious Diseases
- IAVI, Indian Government to Partner on HIV Vaccine Design Program (March 3, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Scientists Develop Nanovaccine Delivery Systems (February 23, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- 2011: 10 HIV Stories to Watch, Part 2 (January 26, 2011)
In Black AIDS Weekly, from Black AIDS Institute
- 2012 HIV Vaccine Conference Coming to Boston, Mass. (December 3, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- North Carolina: Duke to House HIV Vaccine Testing (November 24, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- SciDev.Net Examines Plans for India-S. Africa HIV Vaccine Research Project (October 20, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Media Coverage of HIV Vaccine Conference (October 8, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- HIV/AIDS Researchers, Government Officials Track Progress, Forecast Challenges Ahead for HIV Vaccine Development (September 30, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- NIH Scientists Freeze Virus Fragment in Shape Recognized by Immune System (September 27, 2010)
Development has implications for vaccine design.
From National Institute of Allergy and Infectious Diseases
- Gay Styx Founder Rocks Atlanta, Ga., HIV Research (September 22, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Texas: High-Risk Men Needed for HIV Vaccine Study (September 14, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Crucell, Harvard to Take Part in Experimental AIDS Vaccine Test in Africa (August 20, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Crucell and Harvard to Test Experimental AIDS Vaccine in Uninfected Adults (August 11, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Only 74 Percent of Canadians Would Get HIV Vaccine: Study (August 10, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- An HIV/AIDS Vaccine Breakthrough? On CNN, Community Leaders Offer Perspective: A Blog Entry by Kellee Terrell (July 12, 2010)
From The Body
- Scientists Find Antibodies That Prevent Most HIV Strains From Infecting Human Cells (July 8, 2010)
Discovery to advance HIV vaccine design, antibody therapy for other diseases.
From National Institute of Allergy and Infectious Diseases
- Study Suggests Smallpox Vaccine May Protect Against HIV (May 19, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- AIDS Vaccine Researcher Hopeful (April 26, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- HIV Vaccine Trial Lessons: What Researchers Learned From the STEP Study's Failure and the RV144 ("Thai") Study's Success (March 3, 2010)
A discussion with Nelson Michael, M.D., Ph.D., and Morgane Rolland, Ph.D.
In The 17th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Thai Vaccine Trial Shows Minimal Benefit (Winter/Spring 2010)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Understanding the Results of RV144, the Thai Prime-Boost AIDS Vaccine Trial (March 2010)
To read PDF, click here.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- AIDS Vaccine Effects May Wear Off, Researchers Say (February 19, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- News Outlets Examine HIV Vaccine Research, Cervical Cancer Screening Data Presented at Conference (February 19, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Time Examines HIV Vaccine Efforts (January 19, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- African AIDS Vaccine Conference Addresses Future Trials in Africa, Lower Participation Rates Among Women (December 17, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Virus Used to Transport HIV Vaccine Into Body May Be Behind Failure, Study Suggests (November 17, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Brief Shocks May Deliver AIDS Vaccines Better: Study (October 23, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- AFP Examines Recent HIV Vaccine Findings (October 22, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Media Outlets Examine How AIDS Vaccine Trial Results Will Shape Future Studies (October 21, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- As HIV Vaccine Conference Opens, Experts Appeal for Sustained Commitment to Global Fight Against Disease (October 20, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- New Trial of HIV Vaccine in Gay Men Begins (October 6, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- First Positive Results From Large-Scale HIV Vaccine Trial (September 29, 2009)
Results released from the RV144 trial in Thailand show a prime-boost vaccine combination offers a marginal but statistically significant level of protection against HIV infection.
From International AIDS Vaccine Initiative
- HIV/AIDS Vaccine Is Found to Be Partly Effective at Preventing HIV Infection, but Advocates Express Skepticism (September 28, 2009)
From The Body
- An Unpopular Vaccine Study Produces Surprising Result (September 24, 2009)
From aidsmap.com
- AIDS Vaccine Study Results Explained (September 24, 2009)
From National Public Radio
- IAVI Statement on Results of Phase III ALVAC-AIDSVAX Trial in Thailand (September 24, 2009)
From International AIDS Vaccine Initiative
- Vaccine Reduces Risk of HIV Infection by One-Third in Large Trial (September 24, 2009)
From aidsmap.com
- Massive AIDS Vaccine Study a "Modest" Success (September 24, 2009)
In ScienceInsider
- Anticipating the Results of the Phase III Vaccine Trial in Thailand (PDF) (September 2009)
Preparing for results from the ALVAC-AIDSVAX
Prime-Boost vaccine trial.
From AIDS Vaccine Advocacy Coalition
- HIV Vaccine Regimen Demonstrates Modest Preventive Effect in Thailand Clinical Study (September 24, 2009)
From U.S. National Institute of Allergy and Infectious Diseases
- Investigational Vaccine Shows Modest Potential for Protecting Against HIV Infection (September 24, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- RV144 Phase III HIV Vaccine Trial (September 24, 2009)
U.S. Army and the Thailand Ministry of Public Health join forces to develop a safe and effective preventive HIV vaccine.
To read PDF, click here.
From U.S. Military HIV Research Program
- Frequently Asked Questions Regarding the RV144 Phase III HIV Vaccine Trial (September 24, 2009)
To read PDF, click here.
From U.S. Military HIV Research Program
- HIV Vaccine Study First to Show Some Effectiveness in Preventing HIV (September 24, 2009)
To read PDF, click here.
From U.S. Military HIV Research Program
- AVAC Praises Thai AIDS Vaccine Trial Collaborators and Volunteers for Historic Study (September 24, 2009)
To read PDF, click here.
From AIDS Vaccine Advocacy Coalition
- Issues Surrounding Ending of HIV Vaccine Trial Agreement in Chicago Examined (August 7, 2009)
In Kaiser Daily U.S. HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- IAS Conference: Low-Cost CD4 Tests; HIV Prevalence Among Pregnant Zimbabweans; Treating HIV-TB With ARVs; Vaccine Trials (July 24, 2009)
A brief recap of selected mainstream media coverage of research presented at IAS 2009.
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Prevention, Vaccines Addressed at IAS Conference (July 22, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- South Africa Launches HIV/AIDS Vaccine Trial (July 20, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Human Trials Sought for AIDS Vaccine (July 7, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Clinical Trials in South Africa Help Fight HIV/AIDS (May 26, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Researchers Develop Vaccine Candidate That Is Successful in Blocking Simian Version of HIV (May 18, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Rochester Democrat and Chronicle Examines Area's HIV/AIDS Vaccine Efforts (May 8, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- IAVI Report (PDF) (March-April 2009)
From International AIDS Vaccine Initiative
- AIDS Vaccine Research and Advocacy: An Update (Winter/Spring 2009)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Duke Scientists Find Rare, Potent Antibody to HIV-1 (February 23, 2009)
From Duke Medicine
- HIV Vaccine Development in 2009: Looking Back (and Forward) (February 11, 2009)
Mitchell Warren, the top dog at the AIDS Vaccine Advocacy Coalition, talks about the current state of vaccine development. He explains why, in his opinion, hope on the vaccine front is far from lost.
In The 16th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- NIAID Director Fauci Cancels Planned HIV Vaccine Trial (July 18, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- 2008 AVAC Report The Search Must Continue (May 2008)
From AIDS Vaccine Advocacy Coalition
- AIDS Vaccine Update: Questions After Candidate Fails in the STEP Study (April 2008)
To read PDF, click here.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Summit on HIV Vaccine Research and Development (March 25, 2008)
This is a webcast of the meeting.
From U.S. National Institute of Allergy and Infectious Diseases
- The Failed HIV Vaccine, the HPV Vaccine Hullabaloo and the Future of HIV Prevention (January 2008)
To read PDF, click here.
In HHS Watch, from Community HIV/AIDS Mobilization Project
- IAVI Report Online (2008)
A report on all aspects of AIDS vaccine research and associated scientific disciplines.
From International AIDS Vaccine Initiative
- Merck HIV Vaccine Trial Results: Hopes Dim for Struggling Field (Winter 2008)
To read PDF, click here.
In TAGline, from Treatment Action Group
- Leaders of Merck's Canceled HIV Vaccine Study Notify Participants Whether They Received Vaccine, Placebo (November 14, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Seattle Post-Intelligencer Examines Reactions of People Who Participated in Merck's Canceled HIV Vaccine Trial (November 12, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Questions and Answers: HVTN 502 and HVTN 503 HIV Vaccine Clinical Trials (October 23, 2007)
From U.S. National Institute of Allergy and Infectious Diseases
- An Update Regarding the HVTN 502 and HVTN 503 HIV Vaccine Trials (October 23, 2007)
From U.S. National Institute of Allergy and Infectious Diseases
- Merck Halts International HIV Vaccine Trial (September 24, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Vaccination and Enrollment Are Discontinued in Phase II Trials of Merck's Investigational HIV Vaccine Candidate (September 21, 2007)
From Merck & Co., Inc.
- Predicting the Impact of a Partially Effective HIV Vaccine and Subsequent Risk Behavior Change on the Heterosexual HIV Epidemic in Low- and Middle-Income Countries: A South African Example (September 1, 2007)
In Journal of Acquired Immune Deficiency Syndromes
- AIDS Vaccine Update (July-December 2007)
Disappointment and questions after candidate fails in the STEP study.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Male Circumcision Reduces Men's HIV Infection Risk by 65%, Data Re-Evaluation Says (February 23, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Scientists Unveil Piece of HIV Protein That May Be Key to AIDS Vaccine Development (February 14, 2007)
From U.S. National Institute of Allergy and Infectious Diseases
- Large-Scale Trial of Merck's Experimental HIV Vaccine to Begin in South Africa (February 9, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- VAX Primer: Understanding the Early Stages of HIV Infection (April 2006)
How can studying what happens immediately following HIV infection help researchers design an AIDS vaccine?.
From International AIDS Vaccine Initiative
- Enrolling Women Into HIV Preventive Vaccine Trials: An Ethical Imperative but a Logistical Challenge (February 21, 2006)
In PLoS Medicine
- NIH Launches Phase II Trial of HIV Vaccine for Three Strains of Virus (October 12, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Even an Imperfect HIV Vaccine Can Save Millions of Lives, Report Says (PDF) (October 2005)
[Archived Article]
From International AIDS Vaccine Initiative
- HIV Vaccine's CD4+ Cell-Boosting Properties Lead Merck to Double Enrollment in Study (September 23, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Most in U.S. Hopeful About Development of HIV Vaccine, but Many Fear Participation in Trials, Study Shows (August 9, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- A Promising Alternative: Preclinical Assessment of HIV Vaccines and Microbicides by Repeated Low-Dose Virus Challenges (August 2005)
[Archived Article]
A study by researchers at Emory University and Merck.
In PLoS Medicine
- Indian Government Approves Another HIV Vaccine for Phase I Clinical Trial (July 18, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Phase I Trial of Italian HIV Vaccine Trial Successful, Researchers Say; Phase II To Test Vaccine in Africa (July 7, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Science Magazine Examines Feasibility of HIV Vaccine (July 5, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Health Affairs Focuses on Vaccines, Features Interview With Thompson; Kaiser Family Foundation Describes Media Campaigns (May 12, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- International AIDS Vaccine Initiative Releases Several Working Papers, Brief (April 26, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- India Begins Phase I Clinical Trial for HIV Vaccine Targeting C Strain (February 8, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- NIAID Begins Enrolling Volunteers for Novel HIV Vaccine Study (January 24, 2005)
[Archived Article]
A news release announcing the launch of this Phase II trial, called the Step Study; worldwide study locations and eligibility criteria are listed.
From U.S. National Institute of Allergy and Infectious Diseases
- Timeline for the Initiation of the RV144 Prime-Boost Trial (January 2005)
[Archived Article]
In TAGline, from Treatment Action Group
- Here's My Arm: My Personal Experience Participating in an HIV Vaccine Trial (December 2004)
[Archived Article]
By Gloria Abitol.
In Body Positive, from Body Positive
- Before You Volunteer for an HIV Vaccine Trial ... (December 2004)
[Archived Article]
Some key points to consider before you sign those enrollment forms.
In Body Positive, from Body Positive
- HIV Vaccine Development and Volunteering for Vaccine Trials (December 2004)
[Archived Article]
An interview with Dr. Beryl Koblin, principal investigator for Project ACHIEVE, an AIDS vaccine advocacy organization in New York City.
In Body Positive, from Body Positive
- Keeping Hope Alive: Myths and Facts About HIV Vaccine Trials (December 2004)
[Archived Article]
Communicating the basic concepts around HIV vaccine development involves understanding some simple ideas.
In Body Positive, from Body Positive
- Treble Damages: Three Highlighted Studies From the AIDS Vaccine 2004 Conference (October 2004)
[Archived Article]
Disappointment clouded this year's conference, with new study results suggesting that current approaches to vaccine development aren't panning out.
In TAGline, from Treatment Action Group
- Treatment Action Group Criticizes U.S.-Sponsored RV144 ALVAC/AIDSVAX "Prime-Boost" Vaccine Trial in Thailand (September 28, 2004)
[Archived Article]
In TAGline, from Treatment Action Group
- Slow but Real Progress on the AIDS Vaccine Front (September 3, 2004)
[Archived Article]
Highlights from the AIDS Vaccine 04 conference.
From aidsmap.com
- For HIV-Negative People, the Time to Get Involved Is Now (July/August 2004)
[Archived Article]
HIV-negative people can play a pivotal role in the development of an HIV vaccine by taking part in early clinical trials.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- One Step Forward: Merck Vaccine Moves Forward With Efficacy Trial, While Special Committee Tries to Salvage Thai Study (July 2004)
[Archived Article]
In TAGline, from Treatment Action Group
- ADVAX, New DNA Vaccine in Human Trial; HIV-Negative Volunteers Needed in New York City or Rochester, NY Areas (June 30, 2004)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- Thailand to Present Vaccine Results From Phase III HIV Vaccine Trial During XV International AIDS Conference (June 9, 2004)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Researchers Identify Mutations That Help HIV Avoid Immune Detection; Implications for Vaccine Development (June 2, 2004)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Keystone HIV Pathogenesis and Vaccine Development Report (May/June 2004)
[Archived Article]
Highlights from the Keystone Symposia on Molecular Mechanisms of HIV Pathogenesis (X7) and HIV Vaccine Development (X8), April 12-18, 2004.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Joining a Preventive HIV Vaccine Clinical Trial: Benefits and Risks (May 2004)
[Archived Article]
To read PDF, click here.
In WISE Words, from Project Inform
- HIV More Vulnerable to Vaccine During Acute Infection, Study Suggests (March 26, 2004)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Rwanda to Join African Trials for AIDS Vaccine (March 15, 2004)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Interview With Peggy Johnston, Ph.D., on the Current State of Vaccine Research (Spring 2004)
[Archived Article]
Dr. Johnston is the Director of AIDS Vaccine Research and Prevention at NIAID.
In Positives for Positives, from Wyoming: Positives for Positives
- Scientists Find HIV-Blocking Protein in Monkeys (February 25, 2004)
[Archived Article]
TRIM5-alpha is the first host protein found that specifically targets HIV's capsid.
From U.S. National Institute of Allergy and Infectious Diseases
- Chiron Begins Human Clinical Trials of Combination of Two HIV Vaccines (January 16, 2004)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Group of Scientists Questions Value, Cost of Federally Funded AIDS Vaccine Trial in Thailand (January 16, 2004)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- U.S. Government Defends RV 144, an Ongoing HIV Vaccine Efficacy Trial in Thailand (January 15, 2004)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- The Diabolic Science: VaxGen's Claims of Vaccine Efficacy Evanesce in Autumn's Last Light (October 2003)
[Archived Article]
Further analysis of AIDSVAX's efficacy -- or lack thereof -- in minorities.
In TAGline, from Treatment Action Group
- Merck HIV Vaccines Progress Through Safety Trials (September 2, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- South Africa's Medicines Control Council Approves Country's Second HIV Vaccine Clinical Trial (August 27, 2003)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Botswana Human Rights Group Says Country Offers No Protection to Participants in HIV Vaccine Trial (August 19, 2003)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Researcher Loses HIV Vaccine Data in Durban Mugging (August 6, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- U.S. Company Denies Plan to Abandon AIDS Vaccine Test in Thailand (July 7, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Antibody Discovery Could Lead to HIV Vaccine: Study (July 2, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Race Is On to Save the First AIDS Vaccine. But Does It Even Work? (July 1, 2003)
[Archived Article]
VaxGen pulls out of a final set of trials for its AIDSVAX vaccine amid claims of hype and manipulation.
In The Guardian
- South Africa to Test First Vaccine Against HIV Subtype C (June 20, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Biotech Firm to Test AIDS Vaccine (June 12, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Italian HIV Vaccine Trial Ready to Begin (June 5, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- New HIV Vaccine Shows Promising Results in Preclinical Studies (June 4, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Australian-Developed HIV Vaccine Trial Announced (June 4, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Trials of AIDS Vaccine to Start in India (May 12, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Nabbing the V3 Loop (May 2003)
[Archived Article]
Susan Zolla-Pazner offers new insight into why some anti-V3 loop antibodies have broad HIV neutralizing ability.
In TAGline, from Treatment Action Group
- Starting Anew (Again) (April 2003)
[Archived Article]
CROI 2003 updates on vaccines, siRNA therapy, CEM15 deactivation and the therapeutic value of GBV-C.
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Debate Over Vaccine Trial Results Hits Racial Divide (April 1, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- AIDS Groups Call for Review of AIDS Vaccine Trial Results (March 31, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- HIV's Ability to Rapidly Evolve Occurs Quicker Than Thought (March 21, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Virion-Based Vaccine Protects Macaques Against SIV (March 19, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- First AIDS Vaccine Tested Did Not Protect, But Gives Scientific Leads (March 14, 2003)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- A Worthwhile Test of Hope; Despite Negative Results, Subjects Are Glad They Volunteered for AIDS Vaccine Trial (March 12, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Stirring Up Racial Concerns (March 3, 2003)
[Archived Article]
The media comes under fire for overplaying AIDSVAX's poor study results, and underplaying its possible effectiveness in some minorities.
In San Francisco Chronicle
- AIDSVAX Arbitrary and Post-Hoc Subset Analysis, Up Close (March 2003)
[Archived Article]
In TAGline, from Treatment Action Group
- The VaxGen Study (Spring 2003)
[Archived Article]
In STEP Perspective, from Seattle Treatment Education Project
- Effectiveness of AIDS Vaccine May Be Overstated, Expert Says; Statistics Problem May Account for AIDSVAX Discrepancy (February 27, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Official Hopes to Explain AIDS Vaccine Disparities (February 25, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Controversial HIV Vaccine Trial Results Disappointing (February 25, 2003)
[Archived Article]
From Canadian AIDS Treatment Information Exchange
- NPR Reports on AIDSVAX Trial Results (RealAudio) (February 24, 2003)
[Archived Article]
From National Public Radio
- First AIDS Vaccine in Large Test Found to Be Mostly Ineffective (February 24, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Experiment Shows AIDS Vaccine Unlikely to Give Total Protection From Disease (February 13, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Experimental AIDS Vaccine Being Tested on Humans (January 27, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Willingness to Participate and Enroll in a Phase 3 Preventive HIV-1 Vaccine Trial (December 23, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- VaxGen's AIDS Vaccine to Be Reviewed by FDA (December 17, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- HIV Trick Helps Explain Failed Vaccine Attempts (December 13, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Research From the 42nd ICAAC: Alpha-Defensins, Non-Progressors and Vaccines (December 2002)
[Archived Article]
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Against the Odds, Company Works on AIDS Vaccine (November 22, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- First Human Trial of "Global" HIV Vaccine Launched (November 18, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- New HIV Vaccine Holds Promise of Global Effectiveness (November 13, 2002)
[Archived Article]
From U.S. National Institutes of Health
- HIV's Success Might Lie in Its Mutations (November 6, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- St. Louisan with HIV Is Fighting Off AIDS (September 25, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Researchers Document Rare Case of Second HIV Infection With Different Strain (September 5, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Expert Opinion From Barcelona: Vaccines (September/October 2002)
[Archived Article]
In Positively Aware, from Test Positive Aware Network
- HIV-Specific CD8 T-Cell Activity in Uninfected Injection Drug Users Is Associated With Maintenance of Seronegativity (August 26, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Hope for AIDS Vaccine Fades; News of Superinfection Case (July 11, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- HIV-1 Superinfection: AE Subtype Supplanted by B Subtype (July 11, 2002)
[Archived Article]
In The XIV International AIDS Conference, from The Body PRO
- Harnessing the Immune System to Fight HIV (July 10, 2002)
[Archived Article]
In The XIV International AIDS Conference, from The Body PRO
- Sign of HIV Immunity Reported; Protective Responses Suspected in Two Studies (July 10, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Immune Responses in Long-Term Non-Progressors -- Lessons for Immune Reconstitution (July 10, 2002)
[Archived Article]
In The XIV International AIDS Conference, from The Body PRO
- HIV Selectively Suppresses Anti-HIV Defense Cells (May 1, 2002)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- Clinical Trials of India-Specific Anti-AIDS Vaccine to Start in 2003 (April 22, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Not to Be Sneezed At: Merck's HIV Vaccine Program (April 9, 2002)
[Archived Article]
Updates from Retrovirus 2002.
In TAGline, from Treatment Action Group
- Chimp Adenovirus as New Vaccine Vector (April 9, 2002)
[Archived Article]
Updates from Retrovirus 2002.
In TAGline, from Treatment Action Group
- Franchini's DNA Prime and NYVAC Boost Vaccine (April 9, 2002)
[Archived Article]
Updates from Retrovirus 2002.
In TAGline, from Treatment Action Group
- AIDS Vaccine Moves Ahead in Trials (April 5, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Arizonans to Take Part in Study for an AIDS Vaccine (March 26, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Albany-Area AIDS Vaccine Testers Needed for Study at Albany Medical College (March 19, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Effective AIDS Vaccine Probably at Least a Decade Away, Researcher Says (March 18, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Maryland: Institute of Human Virology Plans Clinical Trial of AIDS Vaccine (March 14, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- NIAID Phase III HIV Vaccine Trial in the United States Will Not Proceed (March 11, 2002)
[Archived Article]
Further explanation for why one of the U.S. government's two vaccine trials is being called off.
To read PDF, click here.
In STEP Ezine, from Seattle Treatment Education Project
- The Impact of Partially Effective HIV Vaccine on a Population of Intravenous Drug Users in Bangkok, Thailand: A Dynamic Model (March 7, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- The Promise of New Vaccine Vectors, the Perils of Partial Protection (March 1, 2002)
[Archived Article]
Two new HIV vaccine studies published in the journal Nature.
In TAGline, from Treatment Action Group
- A Treatment Issues Editorial: Canarypox in the Coal Mine (March 2002)
[Archived Article]
The dangers of moving ahead with huge vaccine trials before the science supports them.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- NIAID Phase III HIV Vaccine Trial to Determine Correlates of Protection Will Not Proceed (February 25, 2002)
[Archived Article]
Phase III trial in Thailand to determine efficacy will be supported by NIAID through a combined NIAID-DoD program.
From U.S. National Institute of Allergy and Infectious Diseases
- Riddle Women: Reports of Progress Toward Understanding How Some People Appear to Fight Off HIV (November 2001)
[Archived Article]
In TAGline, from Treatment Action Group
- First AIDS Vaccine Made at NIAID's Vaccine Research Center Enters Clinical Trial (October 9, 2001)
[Archived Article]
From National Institute of Allergy and Infectious Diseases
- Vaccine Stops Vaginal Transmission of HIV-Like Virus (July 23, 2001)
[Archived Article]
From Reuters Health
- Vaccine Advance: Merck Makes Surprise Announcement of Human Vaccine Trial, Currently Underway (March 2001)
[Archived Article]
In TAGline, from Treatment Action Group
- First HIV Vaccine for Africa Begins Trials (January 26, 2001)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- Simian Success (January 2001)
[Archived Article]
Vaccine study seen as significant advance, but questions remain about human applicability.
In TAGline, from Treatment Action Group
- Status Report on HIV Vaccine Development (Winter 2000)
[Archived Article]
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Vaccine Advance: Monkeys Still Infected, but Protected from Illness (October 20, 2000)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- New Finding on Immune Response to HIV Tat May Contribute to Vaccine, Treatment (September 22, 2000)
[Archived Article]
A study in monkeys has provided important information on how the immune response to HIV develops, why it is usually not sufficient, and how vaccine approaches might be tested more effectively in the future.
In AIDS Treatment News, from AIDS Treatment News
- Promising HIV Vaccine Strategy Identified in Monkey Studies (September 20, 2000)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- New Oral DNA Vaccine Funded for Trials (June 2, 2000)
[Archived Article]
A new kind of vaccine uses a harmless bacterium to deliver selected parts of HIV to immune cells in the intestinal membranes.
In AIDS Treatment News, from AIDS Treatment News
- Vaccine Notes from the Cent Gardes (January 2000)
[Archived Article]
In TAGline, from Treatment Action Group
- Silent Soldiers -- The AIDSVAX Army (September/October 1999)
[Archived Article]
One man's enlistment into the new era of AIDS activism.
In Positively Aware, from Test Positive Aware Network
- Economics of AIDS Vaccines (August 30, 1999)
[Archived Article]
From International AIDS Economics Network (IAEN)
- Combination HIV Vaccine Induces Diverse Immune Responses (July 13, 1999)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- NIH Dedicates New Vaccine Research Center to Dale and Betty Bumpers (June 9, 1999)
[Archived Article]
From U.S. National Institutes of Health
- HIV Antibody Breakthrough in Transgenic Mice Could Prove Boon to Vaccine Effort (June 1999)
[Archived Article]
From Treatment Action Group
- REMUNE Trial Will Stop; New Trials Planned (May 21, 1999)
[Archived Article]
From AIDS Treatment News
- Status of AIDS Vaccine Research at the National Institutes of Health (NIH) (May 18, 1999)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- Second Annual AIDS Vaccine Day Honors Volunteers Nationwide (May 13, 1999)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- Gates Foundation Donates $25 Million for AIDS Vaccine (May 7, 1999)
[Archived Article]
From AIDS Treatment News
- U.S. Vaccine Trial: New Email List (May 7, 1999)
[Archived Article]
From AIDS Treatment News
- The Role of CD8+ Lymphocytes in the Control of SIV Viremia (April 21, 1999)
[Archived Article]
By Jeffrey T. Safrit, Ph.D.
From U.S. National Institute of Allergy and Infectious Diseases
- Status of Current HIV-1 Vaccine Strategies (Table) (March 1999)
[Archived Article]
From Treatment Action Group
- AIDSVax Field Trial Makes a Splash While Humble Canarypox Phase II Plods Along Uncelebrated (March 1999)
[Archived Article]
From Treatment Action Group
- Breakthrough in AIDS Vaccine Development (March 1999)
[Archived Article]
In Body Positive, from Body Positive
- NIAID Opens First AIDS Vaccine Trial in Africa (February 8, 1999)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- New Studies Offer Clues to AIDS Vaccine Design and Safety (February 1, 1999)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- Major Vaccine Project: Largest AIDS Research Grants Ever to Two "Most Promising" Approaches (December 4, 1998)
[Archived Article]
From AIDS Treatment News
- Stimulating Vaccine Development: The First Annual Conference on Vaccine Research (November 1998)
[Archived Article]
In Journal of the International Association of Physicians in AIDS Care, from International Association of Physicians in AIDS Care
- AmFAR RFPs: Immune Reconstitution, HIV Vaccines (October 16, 1998)
[Archived Article]
From AIDS Treatment News
- Large HIV Vaccine Trial Begins (October 1998)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Treatment News: Looking at AIDSVAX and Other Vaccine Trials (October, 1998)
[Archived Article]
By Nina Marks, in Positive Living newsletter.
In Positive Living, from AIDS Project Los Angeles
- Chat with an AIDSVAX Volunteer (October 1998)
[Archived Article]
Nina Marks talks to Bert DaFonte, in Positive Living newsletter.
In Positive Living, from AIDS Project Los Angeles
- AIDS Research: NIH Concocts a Booster Shot for HIV Vaccines (August 28, 1998)
[Archived Article]
By Jon Cohen, from Science magazine.
In Science
- One Part Aged Innovation, Two Parts Hubris: Is Remune Merely Reheated '93 Berlin Fare? (August/September 1998)
[Archived Article]
From Treatment Action Group
- HIV-Specific Immune Responses Restored by HIV Immunogen (July 10, 1998)
[Archived Article]
From AIDS Treatment News
- Jubilation, and Skepticism, Greet Announcement of First Phase III Trial of an AIDS Vaccine (July 1998)
[Archived Article]
From Treatment Action Group
- Vaccine Approaches Currently In Development (July 1998)
[Archived Article]
In Body Positive, from Body Positive
- Body & Soul: Unsung AIDS Advance (June 23, 1998)
[Archived Article]
One vaccine breakthrough overshadows another.
In The Village Voice
- Agouron and Immune Response to Commercialize Remune™ Immune-Based Treatment (June 22, 1998)
[Archived Article]
From AIDS Treatment News
- AIDS Vaccine: Major Report Available (May 15, 1998)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- Nine Years and Counting: Will We Have an HIV Vaccine by 2007? (May 1998)
[Archived Article]
An Agenda for Action for an HIV Vaccine.
From AIDS Vaccine Advocacy Coalition
- First Human Trial Shows that an Edible Vaccine is Feasible (April 27, 1998)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- David Gold Speaks Out on the Need for an HIV Vaccine (March 1998)
[Archived Article]
In Body Positive, from Body Positive
- Novel Concepts Put to the Test in Three New AIDS Vaccine Trials (January 29, 1998)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- The Debate Over How to Proceed with Vaccine Development Efforts (January 1998)
[Archived Article]
From Treatment Action Group
- Heavy Volunteer Response to Possible Experimental Vaccine (November 1997)
[Archived Article]
In Body Positive, from Body Positive
- IAPAC's Editorial (November 1997)
[Archived Article]
Proposed human safety trial of a live-attenuated HIV vaccine raises ethical questions.
In Journal of the International Association of Physicians in AIDS Care, from International Association of Physicians in AIDS Care
- Fifty Volunteer for Live-Vaccine Trial (October 3, 1997)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- Update On HIV Vaccines (August 18, 1997)
[Archived Article]
In STEP Perspective, from Seattle Treatment Education Project
- IAPAC Challenges Physicians, Advocates to Volunteer for AIDS Vaccine Trial (August 1997)
[Archived Article]
From International Association of Physicians in AIDS Care
- IAPAC's Editorial (August 1997)
[Archived Article]
On a Physician-Volunteer Initiative for Live-Attenuated Vaccine Trials.
In Journal of the International Association of Physicians in AIDS Care, from International Association of Physicians in AIDS Care
- The State of the Art: HIV Vaccines (Summer 1997)
[Archived Article]
In The Direct Information on Research and Treatment Newsletter, from ARIC
- AIDS Action Welcomes President Clinton's Call for HIV Preventative Vaccine in Next Decade (May 18, 1997)
[Archived Article]
From AIDS Action Council
- HIV Vaccines Need to Be Developed: Interview with Sam Avrett, International AIDS Vaccine Initiative (May 1, 1997)
[Archived Article]
From AIDS Treatment News
- Clinical Research on HIV/AIDS Vaccines (May 1997)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- Challenges in Designing HIV Vaccines (May 1997)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- AIDS Vaccine Panel Discussion at the Meeting of the Presidential Advisory Council on HIV and AIDS (April 7, 1997)
[Archived Article]
From Harvard AIDS Institute
- AmFAR Awards More Than $800,000 in New Research Grants Including Novel Vaccine and Treatment Studies (February 1997)
[Archived Article]
From amfAR, The Foundation for AIDS Research
- Challenges in Designing HIV Vaccines (January 1997)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- Vaccine Report Available (December 20, 1996)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- Honing the Immune Attack on HIV (December 1996)
[Archived Article]
Research on therapeutic vaccines.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Industry Investment in HIV Vaccine Research (December 1996)
[Archived Article]
In Industry Investment in HIV Vaccine Research, from AIDS Vaccine Advocacy Coalition
- rGP-160 Treatment Vaccine (VaxSyn): Canadian Study Finds No Benefit (April 19, 1996)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- Slow Progress On HIV Vaccines (April 1996)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Long-term Non-Progressors May Hold Clue to Vaccine (April 1996)
[Archived Article]
In HIV Newsline, from San Francisco General Hospital
- New Anti-HIV Vaccine and KS Trials at the National Cancer Institute (February 1996)
[Archived Article]
By Robert Yarchoan, M.D., Chief, Retroviral Diseases Section, MB, DCS.
From National Cancer Institute
- Salk Immunogen: An Immune-Based Therapy in Human Trials Since 1988 (Summer 1995)
[Archived Article]
In Direct Information on Research and Treatment Newsletter, from ARIC
- Report on Drug Development from the HIV Immune-based Therapies Workshop (March 1995)
[Archived Article]
In TAGline, from Treatment Action Group
- NIAID Scraps Large Scale Vaccine Trial (July 1994)
[Archived Article]
In TAGline, from Treatment Action Group
- The International AIDS Vaccine Initiative
[Archived Article]
|
Advertisement
|
Email
Glossary
